Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects
Clinical trial NCT06995001 · COMPLETED
Trial details
- NCT number
- NCT06995001
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-28
- Primary completion
- 2024-11-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.